• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies.

作者信息

Tiong Ing S, Reynolds John, Bradstock Kenneth F, Seymour John F, Wei Andrew H

机构信息

Department of Clinical Haematology, Alfred Hospital and Monash University, Melbourne, Australia.

Biostatistics Platform, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.

出版信息

Blood Cancer J. 2018 Aug 22;8(9):84. doi: 10.1038/s41408-018-0121-4.

DOI:10.1038/s41408-018-0121-4
PMID:30190488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6127140/
Abstract
摘要

相似文献

1
Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies.
Blood Cancer J. 2018 Aug 22;8(9):84. doi: 10.1038/s41408-018-0121-4.
2
Lomustine in older patients with acute myeloid leukaemia.洛莫司汀用于老年急性髓系白血病患者。
Lancet Oncol. 2018 Nov;19(11):e584. doi: 10.1016/S1470-2045(18)30740-X. Epub 2018 Oct 4.
3
Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials.帕比司他单药治疗及联合治疗急性髓系白血病患者：两项临床试验的结果
Haematologica. 2018 Jan;103(1):e25-e28. doi: 10.3324/haematol.2017.172411. Epub 2017 Oct 19.
4
[Acute myeloid leukemia: from risk-adapted to genotype-specific therapy].[急性髓系白血病：从风险适应性治疗到基因型特异性治疗]
Dtsch Med Wochenschr. 2011 Aug;136(31-32):1577-80. doi: 10.1055/s-0031-1281556. Epub 2011 Aug 1.
5
Escalated anthracycline dose in adult AML.成人急性髓系白血病中蒽环类药物剂量的增加
Lancet Oncol. 2017 May;18(5):e253. doi: 10.1016/S1470-2045(17)30277-2. Epub 2017 Apr 13.
6
Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review.老年急性髓系白血病患者治疗方案的有效性和安全性：系统文献回顾。
Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e303-e314. doi: 10.1016/j.clml.2018.05.003. Epub 2018 May 10.
7
Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia.mTOR抑制剂依维莫司联合低剂量阿糖胞苷用于老年急性髓系白血病的Ib期研究。
Leuk Lymphoma. 2018 Feb;59(2):493-496. doi: 10.1080/10428194.2017.1334122. Epub 2017 Jun 8.
8
A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia.吉妥珠单抗奥佐米星联合柔红霉素-阿糖胞苷与其他治疗方案用于初诊急性髓系白血病的比较评价。
Future Oncol. 2019 Feb;15(6):663-681. doi: 10.2217/fon-2018-0512. Epub 2018 Nov 19.
9
A network meta-analysis of randomized controlled trials of induction treatments in acute myeloid leukemia in the elderly.一项关于老年急性髓系白血病诱导治疗的随机对照试验的网络荟萃分析。
Clin Ther. 2011 Mar;33(3):254-79. doi: 10.1016/j.clinthera.2011.04.004.
10
Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials.
Leukemia. 2009 Apr;23(4):811-3. doi: 10.1038/leu.2008.305. Epub 2008 Nov 6.

引用本文的文献

1
Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach.通过澳大拉西亚白血病与淋巴瘤组的共识方法批准急性髓系白血病强化诱导化疗的疗效和安全性。
Intern Med J. 2025 May;55(5):749-759. doi: 10.1111/imj.70010. Epub 2025 Mar 7.
2
Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy.急性肾损伤会对接受诱导化疗的急性髓系白血病患者的临床病程产生不良影响。
Ann Hematol. 2021 May;100(5):1159-1167. doi: 10.1007/s00277-021-04482-3. Epub 2021 Mar 11.
3

本文引用的文献

1
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.阿柔比星剂量递增在成人急性髓系白血病巩固治疗中的应用。
J Clin Oncol. 2017 May 20;35(15):1678-1685. doi: 10.1200/JCO.2016.70.6374. Epub 2017 Apr 3.
2
Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study.医院规模对急性髓系白血病化疗患者结局的影响：一项匹配队列研究。
Blood. 2015 May 21;125(21):3359-60. doi: 10.1182/blood-2015-01-625764.
3
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia.
From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia.
从实验室到临床及其他：急性髓系白血病的治疗方案
Cancers (Basel). 2020 Feb 4;12(2):357. doi: 10.3390/cancers12020357.
一项关于预防性使用帕利夫明对急性髓细胞白血病强化诱导治疗后胃肠道毒性影响的随机试验。
Br J Haematol. 2014 Dec;167(5):618-25. doi: 10.1111/bjh.13086. Epub 2014 Aug 21.
4
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.高剂量阿糖胞苷诱导治疗可改善年龄<46 岁成人急性髓系白血病患者的预后：EORTC-GIMEMA AML-12 试验结果。
J Clin Oncol. 2014 Jan 20;32(3):219-28. doi: 10.1200/JCO.2013.51.8571. Epub 2013 Dec 2.
5
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.在英国医学研究理事会试验中治疗的 5876 例年轻成年患者中，对罕见重现染色体异常进行细胞遗传学分类的细化：确定其预后意义。
Blood. 2010 Jul 22;116(3):354-65. doi: 10.1182/blood-2009-11-254441. Epub 2010 Apr 12.
6
Anthracycline dose intensification in acute myeloid leukemia.急性髓系白血病中蒽环类药物剂量强化
N Engl J Med. 2009 Sep 24;361(13):1249-59. doi: 10.1056/NEJMoa0904544.
7
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005.急性髓系白血病患者生存率的提高：一项基于瑞典1973年至2005年间确诊的9729例患者的人群研究。
Blood. 2009 Apr 16;113(16):3666-72. doi: 10.1182/blood-2008-09-179341. Epub 2008 Nov 19.
8
Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century.21世纪初被诊断为急性髓细胞白血病的成年人存活率的提高。
Haematologica. 2008 Apr;93(4):594-600. doi: 10.3324/haematol.12304. Epub 2008 Mar 5.
9
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.泊沙康唑与氟康唑或伊曲康唑对中性粒细胞减少患者的预防作用比较
N Engl J Med. 2007 Jan 25;356(4):348-59. doi: 10.1056/NEJMoa061094.
10
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.一项关于高剂量与常规剂量阿糖胞苷用于巩固化疗的随机试验，该巩固化疗针对接受含高剂量阿糖胞苷诱导治疗后首次缓解的成年初治急性髓细胞白血病患者。
Blood. 2005 Jan 15;105(2):481-8. doi: 10.1182/blood-2004-01-0326. Epub 2004 Jun 22.